Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses

Signal Transduct Target Ther. 2021 May 10;6(1):182. doi: 10.1038/s41392-021-00608-1.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • COVID-19*
  • Epithelial Cells
  • Humans
  • Lenalidomide
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus* / genetics

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Angiotensin-Converting Enzyme 2
  • Lenalidomide